Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Erbitux
Erbitux
FDA Approves Pfizer's Braftovi Plus Cetuximab for Colorectal Cancer with BRAF Mutations
BioSpace
Thu, 04/9/20 - 11:34 pm
FDA
Pfizer
Braftovi
Erbitux
metastatic colorectal cancer
Array, Pierre Fabre bowel cancer therapy ‘could replace chemo’
Pharmaforum
Mon, 07/8/19 - 09:48 am
Braftovi
Array Biopharma
Pierre Fabre
Eli Lilly
Mektovi
Erbitux
colorectal cancer
clinical trials
What Drove Eli Lilly’s Oncology Franchise in 1Q16?
Yahoo/Market Realist
Wed, 05/4/16 - 08:55 am
Eli Lilly
oncology
Alimta
Erbitux
Cyramza
Portrazza
Merck KGaA bets on cancer drugs to revitalize German firm
Yahoo/Reuters
Mon, 10/12/15 - 09:16 am
Merck KGaA
cancer
Merck Serono
Rebif
Erbitux
Lilly, Bristol-Myers Squibb Restructure Erbitux® (cetuximab) Collaboration in North America
Yahoo
Thu, 04/16/15 - 01:06 pm
Eli Lilly
Bristol-Myers Squibb
Erbitux
The top 10 most expensive drugs of 2013
Fierce Pharma
Tue, 10/14/14 - 10:05 am
drug pricing
Soliris
Alexion
Naglazyme
Biomarin
Kalydeco
Vertex
Cinryze
Shire
Sprycel
Bristol-Myers Squibb
Pomalyst
Celgene
Xyrem
Jazz Pharmaceuticals
Erbitux
Merck KGaA
Revlimid
Questcor
Mallinckrodt
H.P. Acthar Gel
ASCO Meeting Day 3: Do More Treatments Equal A Longer Life?
Yahoo/Benzinga
Thu, 06/5/14 - 09:14 am
ASCO
Pfizer
Aromasin
tamoxifen
DARA Biosciences
breast cancer
Herceptin
Tykerb
GSK
Eli Lilly
Bristol-Myers Squibb
Erbitux
Germany's Merck sees long-term growth in cancer drug Erbitux
Yahoo/Reuters
Fri, 10/4/13 - 10:27 am
Erbitux
Merck KGaA
Avastin
colorectal cancer
Merck KGaA's Drug Tops Roche's Avastin for Colon Cancer
Bloomberg
Sat, 09/28/13 - 11:46 am
Merck KGaA
colon cancer
Roche
Avastin
Erbitux
Erbitux Tops Roche’s Avastin for Colon Cancer Survival
Bloomberg
Sat, 06/1/13 - 12:42 pm
Erbitux
Roche
Avastin
colon cancer
Merck KGaA
Can Bristol-Myers Squibb Compete In Immuno-Oncology?
Seeking Alpha
Mon, 04/8/13 - 11:03 am
immuno-oncology
cancer
Bristol-Myers Squibb
AbbVie
Ariad Pharmaceuticals
JNJ
Eli Lilly
Novartis
Pfizer
Medivation
Erbitux
Yervoy
Sprycel
Orencia
Eli Lilly Sues Genentech Seeking to Invalidate Cabilly Patents
Bloomberg
Sun, 03/3/13 - 11:30 am
Eli Lilly
Genentech
Erbitux
patents
Patent Infringement
lawsuits
Will What Happened to Lilly in 2012 Stay in 2012?
Motley Fool
Tue, 12/18/12 - 11:35 am
Eli Lilly
Zyprexa
Erbitux
animal health
Merck KGaA pulls second lung cancer drug filing
Reuters
Tue, 09/18/12 - 12:04 pm
Merck KGaA
lung cancer
Erbitux
Big Pharmas: New Drugs Will Make You Money
Seeking Alpha
Wed, 08/22/12 - 11:10 am
Abbott Laboratories
JNJ
Bristol-Myers Squibb
Merck
Eli Lilly
Healon EndoCoat
Erbitux
suvorexant
Xarelto
FDA OKs screening test for colon cancer drug
Yahoo/AP
Sat, 07/7/12 - 11:52 am
Qiagen
Erbitux
colon cancer
Bristol-Myers Gets U.S. Approval For Wider Erbitux Use
Bloomberg
Fri, 07/6/12 - 07:21 pm
Bristol-Myers Squibb
colorectal cancer
Eli Lilly
Erbitux
Merck KGaA Says Erbitux Fails In Stomach Cancer Trial
Bloomberg
Thu, 07/5/12 - 12:51 pm
Erbitux
stomach cancer
Merck KGaA
On The Heels Of Chemo-Approved Cancer Drugs
Seeking Alpha
Mon, 04/30/12 - 10:13 am
Eli Lilly
Merck
Northwest Biotherapeutics
Roche
brain cancer
Temodar
Erbitux
DCVax
Avastin
Bristol-Myers Approved to Market Erbitux for Wider Cancer Use
Bloomberg
Mon, 11/7/11 - 09:15 pm
Erbitux
Bristol-Myers Squibb
ImClone
Eli Lilly
head and neck cancer
Pages
1
2
3
next ›
last »